Position in ONC
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$546,572
+$45,287 QoQ
Shares Held
1,918
+13.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 282 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QRG CAPITAL MANAGEMENT, INC. holds $32,600,934 across 24 Biotechnology names. ONC ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,665 | $10,761,655 | |
| 2 | INVA |
Innoviva, Inc.
|
118,767 | $2,697,198 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
24,989 | $2,038,352 | |
| 4 | GMAB |
Genmab A/S
|
72,643 | $1,995,503 | |
| 5 | ARGX |
Argenx SE
|
1,907 | $1,769,257 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
8,083 | $1,513,784 | |
| 7 | INCY |
Incyte Corp
|
13,350 | $1,513,356 | |
| 8 | MRNA |
Moderna, Inc.
|
15,957 | $1,117,468 |
All Filings in ONC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $546,572 | 1,918 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $501,285 | 1,688 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $462,095 | 1,521 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $471,528 | 1,384 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $367,220 | 1,517 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $243,592 | 895 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||